UnknownPhase 1

Evaluation of the Surgical Proficiency and Effectiveness of the Acumed Scapholunate Repair System in Primary Scapholunate Instability Among Canadians

50 participantsStarted 2023-01

Plain-language summary

This study is a prospective, multi-centre, non-randomized, and non-blinded follow-up study to assess the efficacy and effectiveness of the ACUMED® Scapholunate Repair System in primary scapholunate interosseous ligament (SLIL) reconstruction.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Blood supply limitations;
✕. Insufficient quantity or quality of bone support (osteoporosis, metabolic disorders which may impair bone formation, tumor, osteomalacia, etc.).

What they're measuring

Assess surgical proficiencies and effectiveness with the ACUMED® Scapholunate Repair System

Timeframe: Immediately after surgery

Quality of Screw Placement

Timeframe: Immediately after surgery

Trial details

NCT IDNCT04980547

SponsorUniversity of Calgary

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-09

Contact for this trial

Brenna Mattiello, BKin

(403)9563687 brenna.mattiello1@ucalgary.ca

View on ClinicalTrials.gov More Complete Tear of Scapholunate Ligament trials